Employees of companies regulated by the FDA—such as pharmas or biotechs—are no longer allowed to serve as members of FDA ...

Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory ...

The FDA also informed REPL that the agency is not currently planning to hold an advisory committee meeting related to the BLA ...

“Industry employees are welcome to attend FDA advisory committee meetings, along with the rest of the American public, but having industry employees serve as official members of FDA advisory ...

Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as ...

The US Food and Drug Administration (FDA) convenes public advisory committee meetings to address issues in new drug applications (NDAs), biologics license applications (BLAs), or clinical trials ...

“Industry employees are welcome to attend FDA advisory committee meetings, along with the rest of the American public, but having industry employees serve as official members of FDA advisory committee ...

"Industry employees are welcome to attend FDA advisory committee meetings," said Makary, adding that the presence of industry representatives as committee members represents "a cozy relationship ...

Tonix Pharmaceuticals (TNXP) announced that the U.S. Food and Drug Administration will not require an Advisory Committee meeting to discuss ... in 15 years. The FDA previously granted Fast Track ...

This week, Pfizer PFE reported the death of a young boy who participated in a mid-stage study of its Duchenne muscular dystrophy (“DMD”) drug, fordadistrogene movaparvovec. An FDA advisory ...

The US Food and Drug Administration (FDA) convenes public advisory committee meetings to address issues in new drug applications (NDAs), biologics license applications (BLAs), or clinical trials ...